Vinva Investment Management Ltd grew its position in shares of Monster Beverage Co. (NASDAQ:MNST – Free Report) by 4.6% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 43,250 shares of the company’s stock after acquiring an additional 1,903 shares during the quarter. Vinva Investment Management Ltd’s holdings in Monster Beverage were worth $2,269,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Loomis Sayles & Co. L P grew its holdings in shares of Monster Beverage by 4.7% during the 3rd quarter. Loomis Sayles & Co. L P now owns 27,142,970 shares of the company’s stock worth $1,416,048,000 after purchasing an additional 1,229,789 shares during the period. Ninety One UK Ltd grew its stake in Monster Beverage by 93.9% during the second quarter. Ninety One UK Ltd now owns 7,477,852 shares of the company’s stock worth $373,519,000 after buying an additional 3,620,436 shares during the period. Epoch Investment Partners Inc. grew its stake in Monster Beverage by 9.5% during the second quarter. Epoch Investment Partners Inc. now owns 3,174,103 shares of the company’s stock worth $158,546,000 after buying an additional 275,209 shares during the period. Assenagon Asset Management S.A. increased its position in shares of Monster Beverage by 1,148.0% in the third quarter. Assenagon Asset Management S.A. now owns 2,596,888 shares of the company’s stock worth $135,480,000 after acquiring an additional 2,388,798 shares in the last quarter. Finally, DSM Capital Partners LLC raised its stake in shares of Monster Beverage by 13.7% in the 2nd quarter. DSM Capital Partners LLC now owns 2,225,726 shares of the company’s stock valued at $111,175,000 after acquiring an additional 268,198 shares during the period. 72.36% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
MNST has been the subject of a number of research reports. UBS Group upped their price target on shares of Monster Beverage from $55.00 to $57.00 and gave the stock a “neutral” rating in a research report on Friday, November 8th. Royal Bank of Canada decreased their target price on Monster Beverage from $64.00 to $60.00 and set an “outperform” rating for the company in a research report on Thursday, August 8th. TD Cowen raised their target price on Monster Beverage from $50.00 to $55.00 and gave the company a “hold” rating in a report on Monday, November 11th. Jefferies Financial Group decreased their price target on Monster Beverage from $61.00 to $60.00 and set a “buy” rating for the company in a report on Thursday, August 8th. Finally, Truist Financial dropped their price objective on shares of Monster Beverage from $46.00 to $40.00 and set a “sell” rating on the stock in a research note on Friday, August 9th. Two investment analysts have rated the stock with a sell rating, six have issued a hold rating and thirteen have assigned a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $56.45.
Monster Beverage Stock Performance
Shares of MNST stock opened at $55.14 on Friday. The company has a quick ratio of 2.51, a current ratio of 3.13 and a debt-to-equity ratio of 0.13. The business has a 50 day moving average of $53.03 and a two-hundred day moving average of $51.08. The company has a market cap of $53.62 billion, a P/E ratio of 35.35, a PEG ratio of 2.63 and a beta of 0.74. Monster Beverage Co. has a 52 week low of $43.32 and a 52 week high of $61.22.
Monster Beverage Profile
Monster Beverage Corporation, through its subsidiaries, engages in development, marketing, sale, and distribution of energy drink beverages and concentrates in the United States and internationally. The company operates through three segments: Monster Energy Drinks, Strategic Brands, Alcohol Brands, and Other.
Recommended Stories
- Five stocks we like better than Monster Beverage
- The Basics of Support and Resistance
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- How to Use the MarketBeat Stock Screener
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- What Investors Need to Know to Beat the Market
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for Monster Beverage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monster Beverage and related companies with MarketBeat.com's FREE daily email newsletter.